Potential breakthrough in treatment of rare disease

Biotech company Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the life-limiting, rare disease mucopolysaccharidosis II (MPS II) (also known as Hunter syndrome). Occurring in around 1 in...

Closing the Loop on personalised healthcare

Precision medicine using personalised treatments has entered mainstream healthcare. Closed Loop Medicine Ltd aims to level the playing field further with its drug and digital combination products. The Cambridge-based healthcare company is developing drug and...

Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment

By Rashed Karim Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...

Entangled exploring the influences on brain development

Throughout history, much attention has been paid to the perceived differences between men’s and women’s brains – but are these differences real or imagined? One scientist overturning the myths of the ‘male’ and ‘female’ brain...

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s

The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage Study suggests increasing blood flow in the hippocampus might be really effective at preventing...

Researchers are making great strides

We have made great strides in the fight against heart disease over the past 50 years. Since 1961, when the British Heart Foundation was established, the annual number of deaths from CVD in the...

Biosimilars set to make significant UK impact

Biosimilar medicines - equivalent biological products which have no meaningful differences from the original or reference product in terms of quality, safety or efficacy - are playing an important role in providing choice for...

Stanford shows that breast cancers punch tunnels into neighbouring tissue

Stanford researchers have found that malignant breast cancer cells can extend protrusions known as invadopodia to dig escape tunnels through surrounding tissue, revealing a possible new target for therapies. Cancers pose the greatest danger when...

Hope as research unlocks the secrets of heart disease

By Frances Griss Since the beginning of the 1960s, deaths from heart disease in the UK have halved so that today only 26% of people have a cause of death attributable to the condition, compared with...

Build-up of brain proteins affects genes in Alzheimer’s disease

New research has shed fresh light on how the build-up of two proteins in the brain might affect the activity of genes involved in Alzheimer’s disease. Researchers at the University of Exeter worked in collaboration...

Simplicity is all

In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all. “Way back in school, we...

CRYONISS EARNS COVETED MHRA QUALITY MARK

Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen. The Cheshire-based team has a wealth of experience in supporting...

Former Prime Minister takes on key Dementia research role

Former Prime Minister David Cameron has become the new President of Alzheimer’s Research UK, the UK’s leading dementia research charity. Mr Cameron made dementia a major focus of his time in office, launching the Prime...

Research offers hope

There is hope in the battle against drug-resistant drugs, though. For example, a newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB),...

Research reveals how Tau aggregates can contribute to cell death in Alzheimer’s disease

New evidence suggests a mechanism by which progressive accumulation of Tau protein in brain cells may lead to Alzheimer’s disease. Scientists studied more than 600 human brains and fruit fly models of Alzheimer’s disease...

How chromosomes find a happy medium

By Sabrina Richards Staff writer at Fred Hutchinson Cancer Research Center Hutch scientists show how chromosomes communicate to balance crossovers during sex-cell formation Scientists at Fred Hutchinson Cancer Research Center have worked out the molecular underpinnings of...